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Abstract: Depression and type 2 diabetes (T2D) contribute significantly to global burden of disease
and often co-occur. Underpinning type 2 diabetes is poor glycaemic control and glucose is also
an obligatory substrate for brain metabolism, with potential implications for cognition, motivation
and mood. This research aimed to examine the relationships between fasting plasma glucose and
depressive symptoms in a large, population representative sample of US adults, controlling for
other demographic and lifestyle behavioural risk factors. Using the 2013–2014 National Health and
Nutrition Examination Survey (NHANES) data, this study first investigated the relationship between
fasting plasma glucose and mental disorders at a population-level, accounting for demographic,
health behavioural and weight-related factors known to co-occur with both type 2 diabetes and mental
disorders. Depressive symptoms were derived from the 9-item Patient Health Questionnaire. Fasting
plasma glucose was obtained through medical examination and demographic (age, household income,
sex) and health characteristics (perceived diet quality, daily time sedentary) were self-reported. Body
mass index was calculated from objectively measured height and weight. In the univariate model,
higher fasting plasma glucose was associated with greater depressive symptoms among females
(b = 0.24, 95% CI = 0.05, 0.43, p < 0.05), but not males. In the final fully adjusted model, the relationship
between fasting plasma glucose and depressive symptoms was non-significant for both males and
females. Of all independent variables, self-appraised diet quality was strongly and significantly
associated with depressive symptoms and this remained significant when individuals with diabetes
were excluded. Although diet quality was self-reported based on individuals’ perceptions, these
findings are consistent with a role for poor diet in the relationship between fasting plasma glucose
and depressive symptoms.
Keywords: fasting plasma glucose; depression; population health; lifestyle; diet quality
1. Introduction
Depression and non-communicable diseases (NCDs) including type 2 diabetes (T2D), cardiovascular
disease and obesity, are leading contributors to burden of disease and, are often comorbid [1]. The clinical,
environmental and lifestyle antecedents for NCDs are widely recognised and subsequently promoted
as key targets in prevention and treatment [2]. The possibility for shared underlying risk factors for
the development and expression of common mental disorders (CMDs) such as anxiety and depression,
particularly lifestyle related factors, has also been recently promoted [3]. For example, research
demonstrates that although the determinants of mental health are complex, dietary patterns including
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high intake of energy, saturated fats and refined sugar, as well as low consumption of fruits and
vegetables have been associated with risk and onset of depression [4–6]. Poor quality of diet is
also a precursor to NCDs through mechanisms including overweight/obesity, high blood pressure,
impaired glucose metabolism, and dyslipidaemia [7]. As such, understanding the relationship between
mental and NCDs is of critical public health importance for primary and secondary prevention, and
for treatment and management of individuals suffering such conditions.
The relationship between depression and T2D is of particular and current interest [8]. These
disorders are often comorbid; individuals with T2D are at increased risk of developing depression
and the reverse has also been shown to be true [9,10]. Underpinning type 2 diabetes is poor glycaemic
control and glucose is also an obligatory substrate for brain metabolism. Poor glycaemic control
may therefore also affect mood, fatigue and cognitive functioning [11,12]. Recent evidence suggests
that glucose dysregulation is associated with a broad range of mental health conditions such as
increased levels of depression, anxiety, stress-related problems, and psychological distress [13–15].
A meta-analysis [16] has shown glucose dysregulation as a potential mechanistic pathway in the
link between depression and type 2 diabetes. However, studies often fail to examine factors which
may provide insight into the relationship and which are known to affect glycaemic dysregulation
and mental health such as diet, physical activity, and overweight/obesity. Gender differences have
also been observed in epidemiological research to date. The recent Global Burden of Disease study
revealed that smoking, high systolic blood pressure and high body mass index (BMI) emerged as
the highest contributors to disability-adjusted life years for men, and high systolic blood pressure,
high body mass index and high fasting plasma glucose were the leading contributing risk factors for
women [17]. The investigation of potential gender specific risk factors for disease onset is of current
and critical importance.
While the potential for targeting joint risk factors for diabetes-related and mental health outcomes
is appealing, the evidence to date is constrained by self-reported behavioural data within specific
sub-groups (e.g., individuals suffering metabolic syndrome [18], middle to older aged adults [19], male
war veterans [20]). As such, the goal of this research is to examine the relationships between fasting
plasma glucose and depressive symptoms in a large, population representative sample of US adults.
Importantly, the study will consider lifestyle behaviour factors known to co-occur with both depressive
symptoms and poor glycaemic control including overweight/obesity, self-appraised diet quality, and
daily time spent sedentary, examined separately for males and females. To our knowledge this is the
first population-level examination of this kind, adopting a joint biomedical, psychosocial and lifestyle
behavioural approach.
2. Materials and Methods
2.1. Study Design
This study investigated the 2013–2014 National Health and Nutrition Examination Survey (NHANES)
data, which forms one component of a series of US population-level representative surveys [21].
The cross-sectional survey aims to capture the health and nutritional status of the US civilian,
non-institutionalised population, and is led by the National Centre for Health Statistics and the
Centres for Disease Control and Prevention. Data collection occurred during interviews within
participants’ homes, and through medical examination and subsequent laboratory assessments
in the Mobile Examination Centre (further details in sub-section below) [22]. The protocols for
the conduct of NHANES were approved by the National Center for Health Statistics institutional
review board (NCHS IRB/ERB), and informed consent was obtained from all participants (NCHS
IRB/ERB protocols #2011-17). The methods, protocols and data collection tools are available at
https://wwwn.cdc.gov/nchs/nhanes/ContinuousNhanes/Default.aspx?BeginYear=2013 [23]. Ethics
exemption was received for this study from Alfred Health, Melbourne, Australia.
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2.2. Participants
A complex, multi-stage cluster sampling probability design was used to sample participants, with
an oversample of groups. The purpose of oversampling was to increase reliability and precision of
estimates of health status indicators for these sub-groups of particular public health interest (more
information available [21]. In 2013–2014 there were 14,332 individuals selected for NHANES and of
those selected, 10,175 (response rate 71%) completed the interview and 9813 (response rate 68.5%)
participated in the medical examination. A total of 2145 participants had fasting plasma glucose
measures and complete (laboratory, questionnaire and medical examination) data available and
were subsequently included in this study. Further details pertaining to the demographic and health
characteristics of this sample are reported in the results section.
2.3. Data Collection
The NHANES interviews were completed by trained interviewers in participants’ homes by
using Computer-Assisted Personal Interview (CAPI) system. The interview includes survey questions
on demographics (e.g., age, sex, race/ethnicity, education, marital status), general health (health
conditions, body composition), and lifestyle variables (e.g., smoking, physical activity, diet, substance
use). Additionally, anthropometric (height, weight) and laboratory analyses (e.g., nutritional biomarkers,
markers of disease risk) were collected in the mobile examination centre (MEC). All samples were shipped
to University of Missouri-Columbia for analysis. Complete information on laboratory procedures
and analyses are available elsewhere. All information summarised here is taken from NHANES
documentation, previously reported [22].
2.3.1. Depressive Symptoms
The nine-item Patient Health Questionnaire (PHQ-9) was used to assess the presence and severity
of depressive symptoms [24]. The tool was initially developed based on criteria from the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and was one of the first questionnaires
to assess symptoms based on clinical diagnostic criteria [25]. The PHQ-9 is used as a brief diagnostic
and severity measure in both research and clinical practice [26]. Criterion validity has been established
for diagnosing major depressive disorder in comparison to standard clinical diagnostic interview [27],
and as an outcome measure to detect depression changes over time [28].
The PHQ-9 tool asks participants how often over the preceding two weeks they have experienced
problems such as; ‘little interest or pleasure in doing things’, ‘feeling down, depressed or hopeless’,
and ‘feeling tired or overeating’. Responses are scored 0–4, where 0 = not at all, and 4 = nearly every
day and total possible scores range from 0 to 27. While diagnostic criteria for depressive disorders
has been reported (e.g., scores > 10 indicate moderate to severe major depression), it was decided that
responses would be reported as continuous to highlight the associations with symptom frequency and
severity. Validity has been previously shown for continuous PHQ scores as a measure of depressive
symptoms [26,29,30].
2.3.2. Fasting Plasma Glucose
Blood samples were collected, processed and stored at the mobile examination centre (MEC),
where participant fasting status (assigned to morning examination session and had fasted at least
nine hours) was assessed prior to collection. There were seven exclusion criteria for participation
including haemophilia and chemotherapy safety exclusions, fasting less than nine hours, or refusing
phlebotomy. Fasting plasma glucose was measured in mg/dL, (converted into mmol/L for analysis in
this study) and the lower detection limit for fasting glucose was 2.0 mg/dL.
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2.3.3. Body Mass Index
Anthropometric measurements were collected in the MEC by trained health examiners using
standardised protocols. Body weight (kg) was measured using a digital weight scale, and standing
height (cm) using a stadiometer. Body Mass Index (BMI = kg/m2) was calculated as a continuous
variable for all participants.
2.3.4. Lifestyle Factors
Data on self-appraised healthfulness of diet was examined as part of the Diet Behaviour and
Nutrition questionnaire, where participants were asked about their beliefs regarding the general quality
of their diet, and participant responses to ‘in general, how healthy is your overall diet?’ were recorded
on a scale of 1 (excellent) to 5 (poor). This measure has been validated against a more comprehensive
dietary index in a US representative sample [31]. Self-appraised diet quality was merged as three levels;
poor, good/fair, excellent/very good. Further, sedentary behaviour was assessed via the Physical
Activity Questionnaire; participants were asked about total time (in minutes/day) spent sitting
on a typical day, including at school, home, commuting, leisure activities (reading, playing cards,
watching TV), time with friends, at a desk/computer, etc., not including time spent sleeping. Time
spent sedentary was calculated as <3 h, 3–5 h, and more than five hours spent sedentary.
2.3.5. Demographics
Detailed data on individual, family and household level demographics were collected from all
participants. Age at screening (years, further stratified as described in the results section), gender
(male/female), and annual household income were all self-reported. Other demographic information
were collected but excluded from the current study as considered not applicable. Age, gender and
household income were selected as appropriate covariates given the onset of mental health problems is
often age-dependent [32]. In addition, gender and relative socio-economic advantage and disadvantage
differences are widely-reported in relation to the prevalence of mental disorders and associated
symptomatology [33].
2.4. Statistical Analysis
Participant characteristics are reported as proportions and means (standard deviations). Sample
sizes are unweighted, whereas proportions and means are weighted using linearized estimates
to account for the sampling strategy and obtain population-representative findings. The fasting
subsample weights were used in all analyses. Differences between males and females were investigated
using regression models, and significance was assumed at p < 0.05. Linear regression models
were completed to examine the relationship between depressive symptoms and fasting glucose
independently (Model 1), then additionally adjusted for covariates age (stratified as indicated in
Table 1) and household income (Model 2), weight status (Model 3), and lifestyle factors in self-reported
healthiness of diet and average daily time spent sedentary (Model 4). Unstandardised coefficients and
associated 95% confidence intervals and p values are reported, as are standardised beta (β) coefficients.
Significance was assumed at p < 0.05. Further analyses were completed to examine the described
relationships with individuals excluded who reported ‘yes’ to whether their doctor had diagnosed
them with diabetes, henceforth referred to as individuals with diabetes (Supplementary Table S1).
All data were analysed using Stata release V.14.1 (Stata Corp., College Station, TX, USA, 2013), and
SPSS V.22 (IBM Corp., Released 2013, IBM SPSS Statistics for Windows, Version 22.0. IBM Corp.,
Armonk, NY, USA).
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Age in years, n (%)
18–24 137 (14.0) 144 (12.4) 281 (13.1)
25–34 159 (17.6) 170 (17.1) 329 (17.3)
35–44 165 (17.9) 191 (17.1) 356 (17.5)
45–54 171 (17.9) 168 (15.1) 339 (16.5)
55–64 172 (15.8) 206 (18.8) 378 (17.3)
65–74 128 (10.8) 140 (11.9) 268 (11.4)
75–80 99 (5.9) 95 (7.6) 194 (6.8)
Annual income USD, n (%)
$0–19,999 232 (16.2) 269 (18.9) 501 (17.6)
$20,000–54,999 382 (33.8) 441 (36.1) 823 (35.0)
$55,000–74,999 110 (12.1) 121 (12.4) 231 (12.3)
$75,000–99,999 106 (12.6) 104 (11.4) 210 (12.0)
$100,000+ 201 (25.3) 179 (21.0) * 380 (23.1)
Depressive symptoms
Depressive symptoms m (SD) (0–27) 2.5 (3.8) 3.6 (4.4) * 3.1 (4.2)
Major depression 1 n (%) 71 (6.4) 127 (10.4) * 198 (8.4)
Glycaemic control
Fasting plasma glucose (mmol/L) m (SE) 5.9 (1.7) 5.7 (1.7) * 5.8 (1.7)
Diabetes, n (%) 120 (9.4) 122 (10.0) 242 (9.7)
Weight status
BMI, m (SD) kg/m2 28.5 (6.2) 29.7 (8.2) * 29.1 (7.3)
Lifestyle factors
How healthy is diet? n (%)
Excellent/very good 319 (29.3) 324 (31.7) 643 (30.5)
Good/fair 656 (65.9) 722 (62.4) 1378 (64.1)
Poor 56 (4.8) 68 (5.9) 124 (5.4)
Daily time spent sedentary n (%)
<3 h 159 (14.9) 189 (16.2) 348 (15.6)
3–5 h 213 (19.9) 233 (20.5) 446 (20.2)
More than 5 h 659 (65.1) 692 (63.2) 1351 (64.2)
a Sample sizes are unweighted and proportions/means are weighted to account for sampling strategy (proportions
may not total to 100% due to rounding); 1 Major Depression is defined as score of equal to or greater than 10 out
of 27, as recommended by PHQ-9 co-authors [26]; m = mean; SD = standard deviation; BMI = body mass index.
* Significant (p < 0.05) difference between males and females.
3. Results
Participant health and demographic characteristics are reported in Table 1, with proportions
weighted to account for the sampling strategy. Females reported significantly (p < 0.05) greater levels
of depressive symptoms (m = 3.6, SD = 4.4) compared to males (m = 2.5, SD = 3.8), in a possible score
of 0–27. The proportion meeting cut-off for potential clinical depression (greater than or equal to 10
out of 27 [26]) was 10% among females and 6% among males. Fasting plasma glucose levels were
significantly higher among males (m = 5.9, SD = 1.6) compared to females (m = 5.7, SD = 1.7) (p < 0.05).
Average BMI was significantly higher among females (m = 29.7, SD = 8.2) compared to males (m = 28.5,
SD = 6.2). Males and females were similar across all other demographic and health characteristics.
Regression findings are reported in Table 2. Higher fasting plasma glucose was associated with
greater depressive symptoms among females in a univariate model (b = 0.24, 95% CI = 0.05, 0.43,
p < 0.05) and this relationship remained significant when age and household income were included in
the model (b = 0.21, 95% CI = 0.03–0.38, p < 0.05). When demographics were included, older age was
significantly associated with increased depressive symptoms among males (b = 0.22, 95% CI = 0.04–0.39,
p < 0.05) and higher household income was associated with lower levels of depressive symptoms for
both males (b = −0.44, 95% CI = −0.64, −0.24, p < 0.05) and females (b = −0.44, 95% CI = −0.78–0.32,
p < 0.05).
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Table 2. Unstandardized (b) and standardized (β) coefficients from linear regression analyses for depressive symptoms (DV) and fasting glucose (mmol/L) (IV),
unadjusted and adjusted for age, gender, income, BMI, diet, time spent sedentary, weighted to account for sampling strategy.
Models
Males n = 1031 Females n = 1114
Unstandardized b 95% CI for b β p Unstandardized b 95% CI for b β p
Model 1
Fasting glucose (mmol/L) 0.08 −0.11, 0.26 0.03 0.420 0.24 0.05, 0.43 0.09 0.013
Model 2 (+demographics)
Fasting glucose (mmol/L) −0.02 −0.22, 0.18 −0.01 0.831 0.21 0.03, 0.38 0.08 0.021
+Age (years) 0.22 0.04, 0.39 0.10 0.015 0.01 −0.13, 0.15 0.00 0.926
+Household income (USD) −0.44 −0.64, −0.24 −0.17 0.000 −0.55 −0.78, −0.32 −0.18 0.000
Model 3 (+weight status)
Fasting glucose (mmol/L) −0.06 −0.25, 0.14 −0.02 0.562 0.13 −0.04, 0.30 0.05 0.142
+Age 0.21 0.04, 0.39 0.10 0.015 0.01 −0.13, 0.15 0.01 0.855
+Household income −0.44 −0.63, −0.24 −0.17 0.000 −0.51 −0.74, −0.28 −0.16 0.000
+BMI (kg/m2) 0.04 −0.01, 0.08 0.06 0.088 0.06 0.02, 0.09 0.11 0.003
Model 4 (+lifestyle factors)
Fasting glucose (mmol/L) −0.09 −0.29, 0.12 −0.04 0.405 0.11 −0.06, 0.28 0.04 0.211
+Age 0.25 0.07, 0.43 0.12 0.007 0.08 −0.06, 0.23 0.03 0.260
+Household income −0.39 −0.58, −0.19 −0.15 0.000 −0.43 −0.66, −0.20 −0.14 0.000
+BMI 0.03 −0.01, 0.08 0.06 0.120 0.04 0.00, 0.07 0.07 0.045
+Self-appraised diet quality
Poor Ref. Ref.
Good/fair −2.46 −4.14, −0.78 −0.31 0.004 −3.31 −4.77, −1.86 −0.36 0.000
Very good/excellent −2.85 −4.58, −1.12 −0.34 0.001 −4.11 −5.64, −2.57 −0.43 0.000
+Daily sedentary time
<3 h Ref. Ref.
3–5 h 0.86 −0.19, 1.92 0.09 0.108 −0.78 −1.68, 0.12 −0.07 0.089
More than 5 h 0.38 −0.33, 1.09 0.05 0.294 0.10 −0.71, 0.91 0.01 0.810
b = unstandardized coefficient; β = standardised coefficient; 95% CI = 95% confidence interval; BMI = body mass index; bolding indicates significance p < 0.05.
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When BMI was additionally included in the model, the relationship between fasting plasma glucose
and depressive symptoms among females became non-significant. The relationship between older
age and increased depressive symptoms remained significant for males (b = 0.21, 95% CI = 0.04, 0.38,
p < 0.05), and the relationship between higher household income and lower depressive symptoms was
mostly unchanged for both males and females. Higher BMI was significantly associated with higher
levels of depressive symptoms among females (b = 0.06, 95% CI = 0.02–0.09, p < 0.05), whereas this
relationship was non-significant among males.
In the final model, fully adjusted for age, household income, BMI, self-reported diet quality and
daily time spent sedentary, the relationship between fasting plasma glucose and depressive symptoms
was non-significant for both males and females. Of all independent variables, self-reported diet
quality was strongly and significantly associated with depressive symptoms. Females who reported
highest quality diet (very good/excellent) also experienced the lowest levels of depressive symptoms
(b = −4.11, 95% CI = −5.64, −2.57, p < 0.05), compared to those who rated their diet as poor. Those
females who reported their diet as good/fair also experienced lower depressive symptoms compared
to those who self-reported their diet as poor (b = −3.31, 95% CI = −4.77, −1.86, p < 0.05). The same
trend was observed among males whereby those rating their diet as very good/excellent experienced
lower levels of depressive symptoms (b = −2.85, 95% CI = −4.58, −1.12, p < 0.05), as did those rating
good/fair (b = −2.46, 95% CI = −4.14, −0.78, p < 0.05), compared to males who self-reported poor
quality of diet. Older age remained significant for males in the relationship with depressive symptoms
(b = 0.25, 95% CI = 0.07, 0.43, p < 0.05), as did higher household income for both males (b = −0.39,
95% CI = −0.57, −0.20, p < 0.05) and females (b = −0.44, 95% CI = −0.68, −0.21, p < 0.05).
Further analyses to examine the above relationships excluding individuals with diabetes, revealed
a non-significant relationship between fasting plasma glucose and depressive symptoms among
females (Supplementary Table S1). Other findings were consistent to those found in the full sample.
4. Discussion
While the relationship between fasting plasma glucose and depressive symptoms was significant
among females, this relationship was attenuated in the final fully adjusted model and non-significant
in the model with diabetics excluded. Self-appraised healthier diet quality and higher household
income were significantly related to lower levels of depressive symptoms for both males and females,
and these findings held true when diabetics were excluded from analysis. Older age appeared to
coincide with increased depressive symptoms among males, and increased BMI was associated to
higher levels of depressive symptoms among females.
To our knowledge this was the first population-level examination of associations between fasting
plasma glucose and depressive symptomatology that adopted a joint biomedical, psychosocial and
health behavioural design. The sample is representative of the wider US population in terms of
prevalence of depression [34], mean fasting plasma glucose [35], BMI [36], and average daily time
spent sedentary [37]. A small (5%) proportion reported their diets to be ‘poor’. Recent epidemiological
trends show the proportion of US adults with poor diets (categorised by foods linked to increased
risk of cardiovascular and metabolic conditions) was approximately 45% [38] and it is likely that
the proportion of participants consuming diets considered poor quality was under-reported. Higher
levels of depression among females compared to males is unsurprising, with prevalence known to
occur at higher rates among females [39]. Males, on average, had higher fasting plasma glucose than
females and gender differences in fasting plasma glucose levels have been previously observed in
the literature [40,41]. Overweight/obesity tends to be more prevalent among females than males,
as previously shown among the US population [42].
Findings among this large, US-representative sample indicated a significant association between
elevated fasting plasma glucose levels and heightened depressive symptoms among females. Clinical
studies suggest both acute and sustained elevation in blood glucose levels may affect cerebral function
and mental state through a variety of metabolic and vascular mechanisms. These include modulation
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of blood flow, insulin sensitivity and tissue glucose uptake [43] possibly leading to neurotransmitter
imbalance [44] neuronal death and loss of memory [45]. Importantly, glucose has been shown to reduce
hypothalamic blood flow and activity, which may ultimately impact motivation, reward processing,
and other components of mental functioning [43]. Given known comorbidity of type 2 diabetes and
mental disorders [9,10], findings here warrant monitoring of glucose levels and other biomarkers,
in addition to psychological, lifestyle behavioural and weight factors, for type 2 diabetes and depression
risk surveillance. The relationship between fasting plasma glucose and depressive symptoms among
females became non-significant when individuals with diabetes were excluded, and this is consistent
with the known comorbidity of diabetes and mental disorders. With high fasting plasma glucose
levels characterising diabetes, it is suggested that the monitoring of depressive symptoms alongside
traditional risk factors for diabetes is warranted, particularly given that all other relationships remained
consistent with the larger sample.
Self-appraised diet quality was significantly associated with depressive symptoms for both males
and females, independent of all other demographic and behavioural factors. While this measure was
limited in that it remains unknown how closely self-appraised diet corresponded to actual dietary
habits, this measure has previously been shown to correlate to a more comprehensive dietary index in
a US representative sample [31]. The observed relationship was unsurprising given mounting evidence
for a diet–depression relationship whereby individuals consuming foods considered unhealthy (e.g.,
processed foods with little nutritional value), more frequently report mental health problems compared to
individuals with healthy diets [46,47]. As discussed, poor diet quality is also a key driver of poor glucose
regulation [48–50]. Dietary strategies are regularly promoted as a therapeutic approach in diabetes and
have benefits on glucose regulation and disease risk in non-diabetic populations [51]. Specifically, there
are associations between greater intakes of whole-grain foods [52] as well as Mediterranean-style diet [53]
and lower fasting glucose. Concurrently, there is consistent evidence supporting the importance of
healthful, ‘traditional’ dietary patterns to the prevention of major depressive disorders [54,55]. In a recent
meta-analysis, a ‘Western’ diet, characterised by highly-processed foods and low fruit and vegetable
intakes, was associated with an increased risk of depression, whereas a traditional ‘healthful’ dietary
pattern, comprising fruits, vegetables, whole grains, and few animal foods and was associated with
decreased risk [56]. Further, in a recent randomised controlled trial, participants allocated to a 12-week
dietary intervention following a Mediterranean-style diet showed significant reductions in depressive
symptoms compared with those in the social support control group, with nearly one third of those in the
dietary group achieving remission [57].
In the current study, women had higher BMI and lower fasting plasma glucose compared to
men at baseline, and there were significant differences in the glucose-depression association between
men and women. Our findings in women are supported by previous studies on gender differences
in adipose tissue distribution and energy (glucose and fat) metabolism [58]. Specifically, women
have a higher body fat percentage and insulin sensitivity, and the relationship between obesity and
depression appears to be more pronounced in women [59,60]. Furthermore, gender differences have
been identified in leading risk factors contributing to global disability-adjusted life years (DALYs) [17].
Smoking, high systolic blood pressure and high BMI emerged as the highest contributors to DALYs
for men, and high systolic blood pressure, high body mass index and high fasting plasma glucose
were the leading risk factors for women [17]. It has been suggested that the global increase of fasting
plasma glucose is likely to be associated with global increases in BMI (significantly associated with
depressive symptoms in this study) thus highlighting the complexity in risk factors and subsequent
health outcomes for men and women.
Beyond fasting plasma glucose and self-appraised diet quality, a number of variables were
associated with increased levels of depressive symptoms including; level of socioeconomic
disadvantage, higher BMI (females) and older age (males). Poorer mental health outcomes and
increased prevalence of common mental disorders have been consistently shown in disadvantaged
communities [61,62]. Such communities also experience poorer access to healthcare and preventive
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measures, low levels of health literacy, and other complex significant health and societal challenges
compared to advantaged communities [63,64]. The findings here demonstrate the ongoing need
for specific psychological support in communities experiencing disadvantage. The finding that
increased BMI was associated with increased levels of depressive symptoms is also consistent with
previous research [65], and as discussed above, could be due to adiposity-related physiological
mechanisms. The bi-directional relationship between overweight/obesity and depression is also widely
reported with sociological, psychological and cultural factors considered to drive this relationship [66].
Further, low mood, perceived stress and depressive symptoms have been associated with higher
intakes of energy-dense, highly palatable (i.e., high-fat, high-sugar) foods, and lower intakes of fruits
and vegetables [67]. While evidence supports the connection between emotion, food choice and
craving, particularly in women [68], it remains unclear whether individuals with depression have poor
long-term diet quality. Finally, the finding that older age among men, but not women, was significantly
associated with depressive symptoms was of particular interest, and this holds potential for future
age- and gender-related epidemiological research.
Limitations
The cross-sectional design of this survey precludes conclusions on causality. While this study was
strengthened by the combined analysis of biomedical, behavioural and psychological factors, many of
the items required self-report thereby limiting the extent to which the data truly reflect health status.
The self-appraised diet quality measure in particular was limited to an individual’s knowledge and
perceptions of diet quality and given significant findings in the relationship with depressive symptoms,
future research is required to comprehensively assess objectively measured dietary intake and mental
health status. We cannot assume that self-appraised diet quality corresponded to actual dietary quality
as this item was self-reported with no criteria except participants’ beliefs. However previous research
has shown consistency between self-appraised diet quality and more comprehensive dietary index,
and is widely accepted for population studies of this size and scale [31]. Further research is also
planned to investigate the directionality of associations between glucose, lifestyle and depression, and
thus extrapolate potential mechanisms at work at a population-level. Physical activity in particular has
been shown to independently mediate the expression of both biomarkers and mental health symptoms,
and was not adequately captured in this study.
5. Conclusions
To our knowledge this is the first study to report the relationship between fasting plasma
glucose and depressive symptoms, in a large US representative population of adults that adopted
a biopsychosocial approach. Our findings indicate that glucose regulation and depressive symptoms
were significantly associated among females, and that self-appraised diet quality was significantly
related to depressive symptoms. Future longitudinal research should aim to examine directionality
and the role of gender in these associations. Understanding the potential for shared underlying risk
factors is an important area of research for the prevention and management of individuals living with
depression, T2D, and indeed, comorbid conditions. This study is a preliminary, albeit critical, step in
building the evidence base for comorbid health outcomes through modifiable risk factors.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/12/1330/s1,
Table S1: Unstandardized (b) and standardized (β) coefficients from linear regression analyses of sub-group with
doctor diagnosed diabetes individuals excluded, for depressive symptoms (DV) and fasting glucose (mmol/L)
(IV), unadjusted and adjusted for age, gender, income, BMI, diet, time spent sedentary, weighted to account for
sampling strategy.
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